Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 26, 2026Small

Inhalable Degradation‐Tunable Hybrid Nanoparticles With Rapid Lysosomal Escape for Dual siRNA Therapy Against NSCLC

View Full Paper
Ask AI
Bookmark
Share

Authors

HWHezhi WangFLFan LiZCZhixiang Cui

Discussion

Loading...

Member takes

Overview

Randomized trial demonstrates enhanced tumor-targeting gene therapy in lung cancer, suggesting improved treatment efficacy.

Key Points

  • This research aims to improve the efficacy of gene therapy for lung cancer by enhancing tumor targeting and drug delivery mechanisms.
  • Engineered inhalable hybrid nanoparticles with polyester shell and lipid core for pulmonary delivery.
  • Utilized a dual siRNA delivery approach to target TGF-β and mutant KRAS pathways.
  • Conducted systematic screening of nanoparticle materials to optimize stability and efficacy during nebulization.
  • Achieved rapid and sustained lysosomal escape, improving transfection efficiency in lung cancer cells.
  • Established significant tumor growth suppression and reduced metastasis through dual-target siRNA therapy.
  • Demonstrated compatibility with commercial nebulizers for clinical use, enhancing translational potential.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/6a65a2e2d3aea3239cd763d1https://doi.org/10.1002/smll.74724
View Full Paper
Ask AI
Bookmark
Share